 | • レポートコード：MRC2203A784 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査資料では、世界の抗菌薬感受性試験市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別（手動式薬剤感受性試験製品、自動式薬剤感受性試験製品、消耗品）分析、種類別（抗菌試験、抗真菌試験、駆虫試験、その他）分析、用途別（診断、薬物送達・開発、疫学、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来の傾向などの項目を掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の抗菌薬感受性試験市場規模：製品別（手動式薬剤感受性試験製品、自動式薬剤感受性試験製品、消耗品） ・世界の抗菌薬感受性試験市場規模：種類別（抗菌試験、抗真菌試験、駆虫試験、その他） ・世界の抗菌薬感受性試験市場規模：用途別（診断、薬物送達・開発、疫学、その他） ・世界の抗菌薬感受性試験市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（biomerieux、Bio-Rad Laboratories, Inc、HiMedia Laboratories、...） ・市場機会・将来の傾向 |
The antimicrobial susceptibility testing market is expected to grow with a CAGR of 5.3% during the forecast period. The major factors attributing to the growth of the market are the increasing prevalence of multidrug-resistant organisms and growing awareness of precision medicine. According to the Centers for Disease Control and Prevention, more than 2.8 million antibiotic-resistant infections happen in the United States every year, and more than 35,000 people die. The increasing number of multidrug-resistant diseases increases the need for antimicrobial susceptibility testing. The rising awareness programs and initiatives for personalized medicine have a positive effect on the growth of the market and the other factor which is playing a pivotal role in taking the antimicrobial susceptibility testing market to the next level is increasing the use of the tests by the pharmaceutical companies. However, stringent regulatory government polices and the challenges associated with antimicrobial susceptibility testing are expected to restrain the growth of the market over the forecast period.
Key Market Trends
Antibacterial segments dominates the global Antimicrobial Susceptibility Testing Market.
- Antibacterial susceptibility testing is used to ascertain the specific drugs which affect the particular bacteria. These tests can guide the physician in drug preference and dosage for difficult-to-treat infections.
- According to Tbfacts.org, there were an estimated 484,000 incident cases of multidrug resistance/ Rifampicin resistance, TB in 2018. Half of these cases were in India (27%), China (14%) and the Russian Federation (9%). There is more about TB in India and TB in China.
- Furthermore, over usage of antibacterial drugs and mutations in bacteria are leading to high rates of bacterial resistance. For instance, overuse of broad-spectrum antibiotics, such as second- and third-generation cephalosporins, greatly hastens the development of methicillin resistance.
- Thus, considering the rising incidence of antimicrobial resistance there will be huge demand of antimicrobial susceptibility testing over the forecast period.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall antimicrobial susceptibility testing market, throughout the forecast period. This is due to factors such as the rising incidence of antibiotic-resistant infections in the region. This is due to the abuse of antibiotics. §According to antibiotic Resistance Threats in the United States 2019 report, about 2.8 million antibiotic-resistant infections occur in the U.S. each year, and more than 35,000 people die as a result. Furthermore, addition, 223,900 cases of Clostridioides difficile occurred in 2017 and at least 12,800 people died.
Furthermore, well-established awareness programs for precision medicine and the use of antimicrobial testing in it drives, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase the market growth.
Competitive Landscape
The antimicrobial susceptibility testing market is moderately competitive and consists of several major players. The market players are focusing on the advancing the technologies, new product launches to expand their market share. For instance, SeLux Diagnostics is developing an antimicrobial susceptibility (AST) platform that it anticipates will meet clinicians’ requirements allowing them to quickly prescribe the correct antibiotics to patients. In April 2020, company has received USD 9.1 million for seeding development of rapid AST platform.
SThe key market players operating in the antimicrobial susceptibility testing market include biomerieux, Bio-Rad Laboratories, Inc, HiMedia Laboratories, Alifax, and Becton Dickinson among others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Multi Drug Resistance Organisms
4.2.2 Rising Use of Antimicrobial Susceptibility Testing by Pharmaceutical Companies
4.2.3 Growing Awareness of Precision Medicine
4.3 Market Restraints
4.3.1 Stringent Government Regulatory Policies
4.3.2 Challenges associated with Antimicrobial Susceptibility Testing
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Manual Antimicrobial Susceptibility Testing
5.1.1.1 MIC strips
5.1.1.2 Susceptibility Plates
5.1.1.3 Others
5.1.2 Automated Antimicrobial Susceptibility Testing Products
5.1.3 Consumables
5.2 By Type
5.2.1 Antibacterial Testing
5.2.2 Antifungal Testing
5.2.3 Antiparasitic Testing
5.2.4 Others
5.3 By Application
5.3.1 Diagnostics
5.3.2 Drug Discovery and Development
5.3.3 Epidemiology
5.3.4 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 biomerieux
6.1.2 Bio-Rad Laboratories, Inc
6.1.3 HiMedia Laboratories
6.1.4 Alifax
6.1.5 Becton Dickinson, and Company
6.1.6 Creative Diagnostics
6.1.7 Resistell AG
6.1.8 Danaher Corporation
6.1.9 Thermo Fisher Scientific Inc
6.1.10 Merck KGaA
7 MARKET OPPORTUNITIES AND FUTURE TRENDS